Zydus Beats Garda with $166 Million All-Cash Takeover of Assertio
Zydus will buy Assertio for $166.4M, paying $23.50/share, giving shareholders more value and taking the company private.
/ 3 items
#ASRT↓
Assertio Shares Jump as Garda Raises All-Cash Buyout Offer to $21.80 Per Share ($153M Deal)
Garda raised bid to $21.80/share cash to buy Assertio, boosting stock ~17%. Deal gives shareholders higher, certain payout.
Assertio Agrees to $125 Million All-Cash Buyout by Garda Therapeutics
Assertio is being bought by Garda for $18/share + possible bonus if Sprix hits goals; deal closes June 2026, company goes private.